{"name":"NewAmsterdam Pharma","slug":"newamsterdam-pharma","ticker":"","exchange":"","domain":"newamsterdampharma.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":22503000,"revenueGrowth":-50.6,"grossMargin":0,"rdSpend":141832000,"netIncome":-203819000,"cash":769284000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Monotherapy obicetrapib","genericName":"Monotherapy obicetrapib","slug":"monotherapy-obicetrapib","indication":"Cardiovascular risk reduction in patients with established coronary heart disease (Phase 3)","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Monotherapy ezetimibe","genericName":"Monotherapy ezetimibe","slug":"monotherapy-ezetimibe","indication":"Hypercholesterolemia (monotherapy)","status":"phase_3"}]}],"pipeline":[{"name":"Monotherapy obicetrapib","genericName":"Monotherapy obicetrapib","slug":"monotherapy-obicetrapib","phase":"phase_3","mechanism":"Obicetrapib inhibits CETP (cholesterol ester transfer protein) to increase HDL cholesterol and reduce LDL cholesterol levels.","indications":["Cardiovascular risk reduction in patients with established coronary heart disease (Phase 3)"],"catalyst":""},{"name":"Monotherapy ezetimibe","genericName":"Monotherapy ezetimibe","slug":"monotherapy-ezetimibe","phase":"phase_3","mechanism":"Ezetimibe inhibits cholesterol absorption in the small intestine by blocking the Niemann-Pick C1-Like 1 (NPC1L1) transporter.","indications":["Hypercholesterolemia (monotherapy)","Primary hyperlipidemia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQSkFJTExwcFBBemFBVzRsNzNOYzdhMWRTVkZ2WlFrSFNZN1lwRi1vNV9Pa3l5MEJidU5NZHZsSlJPR293b1R6djU3dlRFajdmOGhjMFpaOXBRSVFabF9qRDNaQl9MaEtHQUxoTnB4ZURwc0NGSnpMX1pzNmVycnRBalNLRGpJeHVfZkVUaXpkdmhPalFQd1dndzVvYm1pZC12eTFadQ?oc=5","date":"2026-04-08","type":"pipeline","source":"Yahoo Finance","summary":"NewAmsterdam Pharma Company (NAMS): Huge Upside Potential Grabs Attention of Billionaire Stan Druckenmiller - Yahoo Finance","headline":"NewAmsterdam Pharma Company (NAMS): Huge Upside Potential Grabs Attention of Billionaire Stan Druckenmiller","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPV1NVQ1dEbjJuX3Q4VUpiZ3RseXcyYzRHUFZQSzRjbkhQdjhYdzllN2YtSFdzRjEzTlVSQkQyUFpPQzVVemZUblFpSXB5QVkzUUxoWEd4TGdBOG5xRFkwRDN3eUdzUUJPdmsyRGNTdW8xemNhN0pKbloyM1Y3WEVqYkRwMzBoc2Ita1k3MzdKbUJDWHg0Ml94X2c1S3BLUkVLa2RXYXp5NjIxbTB4SlZvUm5PX29lQm1aQzJXVndB?oc=5","date":"2026-04-08","type":"pipeline","source":"Stock Titan","summary":"NewAmsterdam Pharma CFO joins Needham healthcare event on Apr. 13 - Stock Titan","headline":"NewAmsterdam Pharma CFO joins Needham healthcare event on Apr. 13","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTFBWYkYybS1mZnFZVVVwYUI0NzZhZGppVkdFUFdMbFhRRGNuMWNBUWEwb0laWlZnLTlGWGVZUFZ4cjYyODZvd04zenJkSEdsODNTRGV5N0pJSk56bml2QzZEXzNXSdIBY0FVX3lxTFBWYkYybS1mZnFZVVVwYUI0NzZhZGppVkdFUFdMbFhRRGNuMWNBUWEwb0laWlZnLTlGWGVZUFZ4cjYyODZvd04zenJkSEdsODNTRGV5N0pJSk56bml2QzZEXzNXSQ?oc=5","date":"2026-04-08","type":"pipeline","source":"Bitget","summary":"NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference - Bitget","headline":"NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOZG5iV21laXVxZkNqYlF1NFp1RGI0LWRoRmZBMkNVUm1aREtKaUpZY3UtX3ZYdkVBb2k5RDFvUDFLNVpWR0lCeGJ3ZndkUjhxY0dKY0p6TTZXZldpbjd0MnFsUjA5LVlEOFRnMTlUYXRYcldZbkNIbjNhczFadWZ1VWFBSlMybGdnSHZwUHVpWmxCM1FEOVdqVkpXdHlmSTV6Z2pOeXZ1SnR5ZERlWG1zbWFzZ3dFSElZNHc?oc=5","date":"2026-04-07","type":"pipeline","source":"Investor's Business Daily","summary":"NewAmsterdam Pharma Clears Technical Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily","headline":"NewAmsterdam Pharma Clears Technical Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-07","type":"pipeline","source":"simplywall.st","summary":"Does NewAmsterdam Pharma (NAMS) CETP Optimism Point To A Durable Edge In Cardiovascular Treatment? - simplywall.st","headline":"Does NewAmsterdam Pharma (NAMS) CETP Optimism Point To A Durable Edge In Cardiovascular Treatment?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-05","type":"trial","source":"simplywall.st","summary":"A Look At NewAmsterdam Pharma (NAMS) Valuation After Positive Obicetrapib Trial Sentiment And ACC.26 Data Presentations - simplywall.st","headline":"A Look At NewAmsterdam Pharma (NAMS) Valuation After Positive Obicetrapib Trial Sentiment And ACC.26 Data Presentations","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNaFItYUZyNjJzdE9aakxHNk96alA0Z0sxQW5PTndfbHZEVWNielEtVVpTT1dSelN3RTBhNkppS096aTIxU1BfdXBBNkJ2eC1HT09DSjhqUVE5akpCaUJJUXdqVURNa3hpYlRld2VEUEQwcEY1TXlaVkpaeU9XUTI5SjBqT0VDMlhmbS00Skw1VS1ydHlKUklsOHAzMFgzbWNsLTE3LWxUY2IzRjZVSlRYemNvdHhGX2RxSi1rZ2U5cHMwYVQ2LThGblBR?oc=5","date":"2026-04-04","type":"pipeline","source":"Sahm","summary":"NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sahm","headline":"NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPWVRwYURKVUxRSk5SbTZLWHZ4TEY4RkpRZ1d4X0FXSkp2bFlldlFXaHF2cEtkNVlucmhDMVZrWTZ0ZHIxYzdia3BQRDZXV0NDalpGTTFDNk9oLXhONm03YVFYTnRveVZHS3M5N1Z0UDBNdmJienlhamIxNGtvYVAteUhrMk1JTTAzaWxJTDVLTHFzVlpiQlV3eDFMSnhab0xOSGF3ZlRITTFYUdIBsgFBVV95cUxPOEQ0eVVfOWZkSHNnZXh6TExxR05tb2tDVmNFcUtZcnUtWF9xb2RvUFNqYWREZTVsZzhaRFRqSGNjbkJUTFJHbWlMV2dYQW9aWEJFSjhMVnF5V1ZUVTlRYzJNNnI2bTZ0SmxxT1ZZQ2VQYjNINl8tdWlRckJGQUxudlQ1UkNLMjNKakFxN2hJMVFGRUlSaXFLdTlpcU9mQkRPbDh5Rk1rd3h3UTF1MlY4a1JB?oc=5","date":"2026-04-02","type":"earnings","source":"Insider Monkey","summary":"Here’s Why NewAmsterdam Pharma Company N.V. (NAMS) Surged 23% in Q4 - Insider Monkey","headline":"Here’s Why NewAmsterdam Pharma Company N.V. (NAMS) Surged 23% in Q4","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPMWNXOFU2d2llQTdnLXpWSThkWVRRNVc2WGwwc19LaWFjN3NVcFFlT2JTR2xXTXFWd0RmQVRaUHpCSEV2ZEtGR3B6OUNwNE44cWpLVEpwRUNERllEN2RmUHFXY1pzYVRLWDUwcXc3SEdyNjJidjYtQndOWjVBTFdNZUZhV1pDLU9SanNWUG1jV0EzTW9aTHd3VjJtTnFhR2VfRDl5Ujd0ZXJITW1IZmxIejkzXy1nbGRIV3pNZ3VGYw?oc=5","date":"2026-04-02","type":"pipeline","source":"Stock Titan","summary":"Two new hires get 15,000 stock options and 3,200 RSUs at NewAmsterdam - Stock Titan","headline":"Two new hires get 15,000 stock options and 3,200 RSUs at NewAmsterdam","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxNdkxqdG5Fby1pcjFtNnMyR3RkV01WZng5bmRQQ1hid1l2Ymp5dlgxUEhmV1dNc2Y2b1NIMjYxRzV6Wm1kdGh6VVlKcGs1Nlc5MU9jYzZNM1lnSlRrUjlCbUhHY1JhY1FiVmRtaFZZdTZEdC1zSmRGcHRCQTM4TTVtWlBKSmhGN3B2cDhVbkoyb2l4aFdMaDVObjMzNzN1QUpRQzFRZ1UtU0UwekViQUdLMXRTdUVOdGoxVU9sYUJtWVI5TTEzenpzU0NlaXc4MTJTNGM1ZWF3b0hMUkJkbzdEVzViMjRLRDBiTEhXNEhud0Y1Q0R5LWxfVmt1cnZSQTFnSV84WVB3T3Y1Y3JENFQ5cnhueDYydGk1ZkE?oc=5","date":"2026-03-23","type":"pipeline","source":"GlobeNewswire","summary":"NewAmsterdam Pharma Announces Three Presentations at the - GlobeNewswire","headline":"NewAmsterdam Pharma Announces Three Presentations at the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxON1RZWHFkZmJ5R3ZWa3FwWjU3WHRlWmVZTDlRbUdxY19uV2piOU9FR0lPTUZ1SGx0ZEoydzBrWnNHSUczcW1jZU1fcDBoUUJTQldfaGt3NkJiZUt5R2RJdm1kSG92NFZHS1NHX2N0SVZNenN5aTVMeVFYckQ5NVI1U0hYZzlxR01aWmNJNHdLSFR5Nl9mNTJZR2pQbFNHSkdsUEpNLXh3QXZRV0hFMnNsUmJLWjdLanJL?oc=5","date":"2026-03-23","type":"trial","source":"Stock Titan","summary":"A cholesterol pill's kidney and safety data head to a major heart meeting - Stock Titan","headline":"A cholesterol pill's kidney and safety data head to a major heart meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPSlZORjdoYk5NY054Qm15WnZ5cWMwSWJadEdPNjBzaGU2Ny0zNHNsX2sxN3NGdTktRjQ5Szk0UW96c0ZOdmpWb0RDVDh6Z0pmLU1VRUZYMlE3dXFtbHhNZW1Da3ZWeDhtMXJ2Tjdyd0FMcG5ybk9MeEpqNFkxcFVSd3Q3SktxaDdNN05rVEk2SU1LbDV3WGY1WjloUXA3ektFbFRtc0NvcmdkS01xZ1V2bXdkVjZIWlMtZElhbGVEOUU4Y2tHbFE?oc=5","date":"2026-03-18","type":"deal","source":"Investing.com","summary":"Truist initiates NewAmsterdam Pharma stock coverage with buy rating - Investing.com","headline":"Truist initiates NewAmsterdam Pharma stock coverage with buy rating","sentiment":"neutral"},{"date":"2026-03-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-18","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-18","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":22503000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":22503000,"period":"2025-12-31"},{"value":45563000,"period":"2024-12-31"},{"value":45563000,"period":"2024-12-31"},{"value":14090000,"period":"2023-12-31"},{"value":14090000,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":141832000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-203819000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":769284000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}